JP2016536330A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536330A5
JP2016536330A5 JP2016537910A JP2016537910A JP2016536330A5 JP 2016536330 A5 JP2016536330 A5 JP 2016536330A5 JP 2016537910 A JP2016537910 A JP 2016537910A JP 2016537910 A JP2016537910 A JP 2016537910A JP 2016536330 A5 JP2016536330 A5 JP 2016536330A5
Authority
JP
Japan
Prior art keywords
seq
folr1
antibody
antigen
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016537910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016536330A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/053512 external-priority patent/WO2015031815A2/en
Publication of JP2016536330A publication Critical patent/JP2016536330A/ja
Publication of JP2016536330A5 publication Critical patent/JP2016536330A5/ja
Priority to JP2018226360A priority Critical patent/JP6983746B2/ja
Pending legal-status Critical Current

Links

JP2016537910A 2013-08-30 2014-08-29 葉酸受容体1の検出用の抗体及びアッセイ Pending JP2016536330A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018226360A JP6983746B2 (ja) 2013-08-30 2018-12-03 葉酸受容体1の検出用の抗体及びアッセイ

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361872407P 2013-08-30 2013-08-30
US61/872,407 2013-08-30
US201361875475P 2013-09-09 2013-09-09
US61/875,475 2013-09-09
US201461940184P 2014-02-14 2014-02-14
US61/940,184 2014-02-14
PCT/US2014/053512 WO2015031815A2 (en) 2013-08-30 2014-08-29 Antibodies and assays for detection of folate receptor 1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018226360A Division JP6983746B2 (ja) 2013-08-30 2018-12-03 葉酸受容体1の検出用の抗体及びアッセイ

Publications (2)

Publication Number Publication Date
JP2016536330A JP2016536330A (ja) 2016-11-24
JP2016536330A5 true JP2016536330A5 (show.php) 2018-04-05

Family

ID=52587498

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016537910A Pending JP2016536330A (ja) 2013-08-30 2014-08-29 葉酸受容体1の検出用の抗体及びアッセイ
JP2018226360A Active JP6983746B2 (ja) 2013-08-30 2018-12-03 葉酸受容体1の検出用の抗体及びアッセイ
JP2020185082A Withdrawn JP2021035968A (ja) 2013-08-30 2020-11-05 葉酸受容体1の検出用の抗体及びアッセイ
JP2022210118A Active JP7554252B2 (ja) 2013-08-30 2022-12-27 葉酸受容体1の検出用の抗体及びアッセイ
JP2024063894A Pending JP2024095796A (ja) 2013-08-30 2024-04-11 葉酸受容体1の検出用の抗体及びアッセイ

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018226360A Active JP6983746B2 (ja) 2013-08-30 2018-12-03 葉酸受容体1の検出用の抗体及びアッセイ
JP2020185082A Withdrawn JP2021035968A (ja) 2013-08-30 2020-11-05 葉酸受容体1の検出用の抗体及びアッセイ
JP2022210118A Active JP7554252B2 (ja) 2013-08-30 2022-12-27 葉酸受容体1の検出用の抗体及びアッセイ
JP2024063894A Pending JP2024095796A (ja) 2013-08-30 2024-04-11 葉酸受容体1の検出用の抗体及びアッセイ

Country Status (28)

Country Link
US (6) US9637547B2 (show.php)
EP (2) EP3925980A1 (show.php)
JP (5) JP2016536330A (show.php)
KR (3) KR102585409B1 (show.php)
CN (2) CN105814079B (show.php)
AU (3) AU2014312086B2 (show.php)
BR (1) BR112016003665B1 (show.php)
CA (2) CA2921975C (show.php)
CY (1) CY1124428T1 (show.php)
DK (1) DK3038650T3 (show.php)
ES (1) ES2883191T3 (show.php)
HR (1) HRP20211317T1 (show.php)
HU (1) HUE055856T2 (show.php)
IL (2) IL244061B (show.php)
LT (1) LT3038650T (show.php)
MX (2) MX371496B (show.php)
MY (2) MY201478A (show.php)
NZ (1) NZ717140A (show.php)
PL (1) PL3038650T3 (show.php)
PT (1) PT3038650T (show.php)
RS (1) RS62240B1 (show.php)
RU (1) RU2725825C2 (show.php)
SG (3) SG10202100275TA (show.php)
SI (1) SI3038650T1 (show.php)
SM (1) SMT202100471T1 (show.php)
UA (1) UA120166C2 (show.php)
WO (1) WO2015031815A2 (show.php)
ZA (1) ZA201907806B (show.php)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY197016A (en) 2010-02-24 2023-05-20 Immunogen Inc Folate receptor 1 antibodies and immunoconjugates and uses thereof
PT2694106T (pt) * 2011-04-01 2018-03-05 Immunogen Inc Métodos para aumentar eficácia de terapia de cancro de folr1
SG10201804260QA (en) 2012-08-31 2018-07-30 Immunogen Inc Diagnostic assays and kits for detection of folate receptor 1
JP2016536330A (ja) 2013-08-30 2016-11-24 イミュノジェン, インコーポレイテッド 葉酸受容体1の検出用の抗体及びアッセイ
EP4424323A3 (en) * 2013-10-08 2024-11-13 ImmunoGen, Inc. Anti-folr1 immunoconjugate dosing regimens
MA40415A (fr) 2014-09-03 2016-03-10 Immunogen Inc Conjugués comprenant des agents de liaison cellulaire et des agents cytotoxiques
HRP20201747T1 (hr) * 2014-11-20 2020-12-25 F. Hoffmann - La Roche Ag Bispecifične antigen vezujuće molekule koje aktiviraju t stanice, protiv folr1 i cd3
CN107428837A (zh) * 2015-04-22 2017-12-01 免疫医疗公司 循环trop‑2阳性癌细胞的分离、检测、诊断和/或鉴定
WO2017049149A1 (en) 2015-09-17 2017-03-23 Immunogen, Inc. Therapeutic combinations comprising anti-folr1 immunoconjugates
WO2019050935A1 (en) * 2017-09-05 2019-03-14 Immunogen, Inc. METHODS OF DETECTING FOLATE RECEPTOR 1 IN A SAMPLE FROM A PATIENT
CN108152189B (zh) * 2017-12-06 2020-06-05 浙江大学 一种精子表面出云蛋白1的定量检测方法
AU2019236091B2 (en) * 2018-03-13 2025-06-05 Phanes Therapeutics, Inc. Anti-folate receptor 1 antibodies and uses thereof
EA038215B1 (ru) * 2018-06-09 2021-07-26 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр исследований и разработки иммунобиологических препаратов им. М.П. Чумакова РАН" Способ количественного определения антигена вируса желтой лихорадки иммуноферментным анализом с использованием специфических желточных антител и детекторных антител, меченных биотином
KR20220004687A (ko) 2019-04-29 2022-01-11 이뮤노젠 아이엔씨 이중파라토프 fr-알파 항체 및 면역접합체
CN120053680A (zh) * 2019-06-06 2025-05-30 神话治疗股份有限公司 抗原结合蛋白构建体及其用途
JP7489472B2 (ja) 2020-10-27 2024-05-23 エルシダ オンコロジー, インコーポレイテッド ナノ粒子を官能化する方法
CN112794911B (zh) * 2021-04-14 2021-08-03 上海偌妥生物科技有限公司 人源化抗叶酸受体1抗体及其应用
WO2023116911A1 (zh) 2021-12-24 2023-06-29 百奥泰生物制药股份有限公司 抗FRα抗体及其抗体药物偶联物和用途
CA3249553A1 (en) * 2022-03-11 2023-09-14 Astrazeneca Ab METHOD FOR RATING ANTI-FRα ANTIBODY-DRUG CONJUGATE THERAPY
WO2025036307A1 (zh) 2023-08-11 2025-02-20 百奥泰生物制药股份有限公司 抗frα抗体药物偶联物在治疗疾病中的应用
WO2025094146A1 (en) 2023-11-02 2025-05-08 Immunogen Switzerland Gmbh Vasconstrictors for reducing ocular toxicity of antibody-maytansinoid conjugates
CN117700556B (zh) * 2024-02-05 2024-04-12 苏州百道医疗科技有限公司 一种抗FRα小鼠单克隆抗体及其应用
CN117700557B (zh) * 2024-02-05 2024-04-30 卡秋(江苏)生物科技有限公司 一种特异性结合叶酸受体α的抗体或抗原结合片段

Family Cites Families (173)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2046920B1 (show.php) 1969-06-19 1974-05-03 Citizen Watch Co Ltd
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4957939A (en) 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4472509A (en) 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4588585A (en) 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0229046B1 (fr) 1985-03-30 1994-05-04 BALLIVET, Marc Procede d'obtention d'adn, arn, peptides, polypeptides ou proteines, par une technique de recombinaison d'adn
US6492107B1 (en) 1986-11-20 2002-12-10 Stuart Kauffman Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US4938948A (en) 1985-10-07 1990-07-03 Cetus Corporation Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
DE3600905A1 (de) 1986-01-15 1987-07-16 Ant Nachrichtentech Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
US5681718A (en) 1986-03-14 1997-10-28 Celltech Limited Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
WO1989006692A1 (en) 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US20030229208A1 (en) 1988-12-28 2003-12-11 Protein Design Labs, Inc. Humanized immunoglobulins
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
EP0478627A4 (en) 1989-05-16 1992-08-19 William D. Huse Co-expression of heteromeric receptors
CA2016841C (en) 1989-05-16 1999-09-21 William D. Huse A method for producing polymers having a preselected activity
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
JPH049249A (ja) 1990-04-27 1992-01-14 Kusuda:Kk 塗型剤吹き付け機
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6916605B1 (en) 1990-07-10 2005-07-12 Medical Research Council Methods for producing members of specific binding pairs
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
DE69127627T2 (de) 1990-08-29 1998-02-19 Genpharm Int Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
CA2103887C (en) 1991-12-13 2005-08-30 Gary M. Studnicka Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
US5965132A (en) 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US6004554A (en) 1992-03-05 1999-12-21 Board Of Regents, The University Of Texas System Methods for targeting the vasculature of solid tumors
US20030148406A1 (en) 1992-03-17 2003-08-07 David John King Multivalent antigen-binding proteins
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
AU691811B2 (en) 1993-06-16 1998-05-28 Celltech Therapeutics Limited Antibodies
US5432930A (en) 1993-09-30 1995-07-11 Eagle Crest Limited System for accessing cobol data files by generating a dictionary of NF.sup.2
NL9302194A (nl) 1993-12-15 1995-07-03 Nidera Handelscompagnie B V Werkwijze voor het bereiden van een samengevoegd visprodukt, alsmede visprodukt verkregen onder toepassing van deze werkwijze.
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
DE19526926A1 (de) 1995-07-24 1997-01-30 Bayer Ag Verfahren zur Herstellung beladener nichtporöser Trägermaterialien
AU725609C (en) 1995-08-18 2002-01-03 Morphosys Ag Protein/(poly)peptide libraries
US6696248B1 (en) 1995-08-18 2004-02-24 Morphosys Ag Protein/(poly)peptide libraries
JP2002514895A (ja) 1995-09-28 2002-05-21 アレクション、ファーマスーティカルズ、インコーポレーテッド ブタ細胞相互作用タンパク質
US5714352A (en) 1996-03-20 1998-02-03 Xenotech Incorporated Directed switch-mediated DNA recombination
US6596850B1 (en) 1998-01-30 2003-07-22 Ixsys, Incorporated Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
WO2000023082A1 (en) 1998-10-19 2000-04-27 Yeda Research And Development Co. Ltd. Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
WO2001002588A2 (en) 1999-07-02 2001-01-11 Morphosys Ag Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
IT1307309B1 (it) 1999-12-30 2001-10-30 Enea Ente Nuove Tec Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
DZ3332A1 (fr) 2000-03-31 2001-10-11 Purdue Research Foundation Methode de traitement a l'aide de conjugues ligand-immunogene
DE10037759A1 (de) 2000-08-03 2002-07-04 Gruenenthal Gmbh Screeningverfahren
EP1998266A3 (en) 2001-02-19 2009-02-11 Merck Patent GmbH Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity
WO2002071928A2 (en) 2001-03-14 2002-09-19 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
IL158532A0 (en) 2001-05-02 2004-05-12 Purdue Research Foundation Treatment and diagnosis of macrophage mediated disease
US7314974B2 (en) 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
US20060110771A1 (en) 2002-03-01 2006-05-25 Masanao Katagiri Proteins capable of binding to female sex hormones and process for producing the same
CN102659946A (zh) 2002-03-13 2012-09-12 拜奥根Idec马萨诸塞公司 抗αvβ6抗体
CA2482607C (en) 2002-04-22 2013-06-11 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
GB0216648D0 (en) 2002-07-18 2002-08-28 Lonza Biologics Plc Method of expressing recombinant protein in CHO cells
KR101317045B1 (ko) * 2002-09-06 2013-10-16 암젠 인코포레이티드 치료학적 인체 항-il-1r1 모노클로날 항체
AU2003295411A1 (en) 2002-11-07 2004-06-03 Celltech R & D Human monoclonal antibodies to heparanase
EP1481993A1 (en) 2003-05-28 2004-12-01 Xerion Pharmaceuticals AG Modulation of the poliovirus receptor function
WO2004082463A2 (en) 2003-03-17 2004-09-30 Medical College Of Ohio Folate receptor gene modulation for cancer diagnosis and therapy
US20050255114A1 (en) 2003-04-07 2005-11-17 Nuvelo, Inc. Methods and diagnosis for the treatment of preeclampsia
US20050025763A1 (en) 2003-05-08 2005-02-03 Protein Design Laboratories, Inc. Therapeutic use of anti-CS1 antibodies
KR101351122B1 (ko) 2003-05-09 2014-01-14 듀크 유니버시티 Cd20-특이적 항체 및 이를 이용한 방법
CA2930485C (en) 2003-05-14 2018-04-10 Immunogen, Inc. Maytansinoid-antibody conjugate compositions
US7276497B2 (en) 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids
CA2530393A1 (en) 2003-07-02 2005-01-13 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
CA2548942C (en) 2003-12-05 2013-10-15 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Anti-sars monoclonal antibodies
CA2556027C (en) 2004-02-12 2015-11-24 Morphotek, Inc. Monoclonal antibodies that specifically block biological activity of a tumor antigen
US20080187954A1 (en) 2004-03-10 2008-08-07 Lonza Ltd. Method For Producing Antibodies
MXPA06012162A (es) 2004-04-27 2007-03-30 Galapagos Nv Metodos, agentes y ensayos de seleccion de compuestos para inducir diferenciacion de celulas de mamifero no diferenciadas, en osteoblastos.
CA2581208A1 (en) 2004-08-30 2006-03-09 Lonza Biologics Plc. Affinity- plus ion exchange- chromatography for purifying antibodies
US7776869B2 (en) 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
KR20070094890A (ko) 2004-10-25 2007-09-27 머크 앤드 캄파니 인코포레이티드 안티 addl 항체 및 그 용도
AU2005337132B2 (en) 2004-12-21 2011-01-20 Monsanto Technology, Llc Transgenic plants with enhanced agronomic traits
EP1833510A4 (en) 2004-12-27 2010-02-10 Progenics Pharmaceuticals Neva ORAL ADMINISTRATION ANTITOXIN ANTIBODIES AND METHODS OF MAKING AND USING THE SAME
EP1838735A2 (en) 2004-12-31 2007-10-03 Genentech, Inc. Polypeptides that bind br3 and uses thereof
WO2007094754A2 (en) 2005-01-27 2007-08-23 The Regents Of The University Of Califordnia Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
PT2343320T (pt) 2005-03-25 2018-01-23 Gitr Inc Anticorpos anti-gitr e as suas utilizações
US7608413B1 (en) 2005-03-25 2009-10-27 Celera Corporation Kidney disease targets and uses thereof
RU2007139912A (ru) 2005-03-30 2009-05-10 Пердью Рисерч Фаундейшн (Us) Способ прогнозирования течения рака на основе количественного анализа клеточного рецептора витамина фолата
WO2006116592A2 (en) 2005-04-22 2006-11-02 Morphotek, Inc. Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
US7786266B2 (en) 2005-05-12 2010-08-31 Oncotherapy Science, Inc. Methods for damaging cells using effector function of anti-DSC2 antibody
KR101273829B1 (ko) 2005-05-20 2013-06-11 론자 바이올로직스 피엘씨 포유류 숙주 세포에서의 재조합 항체의 고-수준 발현
MX2007014673A (es) 2005-05-24 2008-04-08 Avestha Gengraine Tech Pvt Ltd Metodo para la produccion de un anticuerpo monoclonal para cd20 para el tratamiento de linfoma de celular b.
JP5175723B2 (ja) 2005-07-05 2013-04-03 パーデュー・リサーチ・ファウンデーション 単球介在性疾患を治療するための組成物の調製
US7521195B1 (en) 2005-07-21 2009-04-21 Celera Corporation Lung disease targets and uses thereof
EP1937720B1 (en) 2005-08-18 2014-04-09 Ramot at Tel-Aviv University Ltd. Single chain antibodies against beta-amyloid peptide
JP4938263B2 (ja) 2005-08-19 2012-05-23 独立行政法人農業生物資源研究所 一本鎖抗体によるサイトゾルタンパク質の機能阻害法およびその利用
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
HRP20170444T1 (hr) * 2005-08-31 2017-05-19 Merck Sharp & Dohme Corp. Projektirana anti-il-23 antitijela
WO2007030930A1 (en) 2005-09-13 2007-03-22 National Research Council Of Canada Methods and compositions for modulating tumor cell activity
EP1938104A2 (en) 2005-10-17 2008-07-02 Institute for Systems Biology Tissue-and serum-derived glycoproteins and methods of their use
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
NZ599683A (en) 2005-12-20 2013-11-29 Sbi Biotech Co Ltd Anti-ilt7 antibody
KR20080113236A (ko) 2006-03-21 2008-12-29 와이어쓰 Rage를 길항하기 위한 방법 및 조성물
WO2007143561A1 (en) 2006-06-01 2007-12-13 Mayo Foundation For Medical Education And Research Immunity to folate receptors
JP5564249B2 (ja) 2006-06-23 2014-07-30 アレシア・バイオセラピューティクス・インコーポレーテッド 癌に関与するポリヌクレオチド配列およびポリペプチド配列
US7910702B2 (en) 2006-07-28 2011-03-22 The Governors Of The University Of Alberta Recombinant antibodies to sclerotinia antigens
US8586006B2 (en) 2006-08-09 2013-11-19 Institute For Systems Biology Organ-specific proteins and methods of their use
ES2902063T3 (es) 2006-09-08 2022-03-24 Abbvie Bahamas Ltd Proteínas de unión a interleucina-13
EP1900752A1 (en) 2006-09-15 2008-03-19 DOMPE' pha.r.ma s.p.a. Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
US9017684B2 (en) 2006-10-12 2015-04-28 Chugai Seiyaku Kabushiki Kaisha Diagnosis and treatment of cancer using anti-EREG antibody
JP5632582B2 (ja) 2006-12-14 2014-11-26 中外製薬株式会社 抗Claudin3モノクローナル抗体およびそれを用いる癌の治療および診断
KR101546441B1 (ko) 2006-12-20 2015-08-24 엠엠알글로벌, 인코포레이티드 항체 및 이들의 제조 및 사용 방법
US20080227704A1 (en) 2006-12-21 2008-09-18 Kamens Joanne S CXCL13 binding proteins
US7691980B2 (en) 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US20100104626A1 (en) 2007-02-16 2010-04-29 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
EP2604284A1 (en) 2007-02-16 2013-06-19 KTB Tumorforschungsgesellschaft mbH Receptor And Antigen Targeted Prodrug
CN103396489A (zh) 2007-02-23 2013-11-20 默沙东公司 工程改造的抗IL-23p19抗体
US7915368B2 (en) * 2007-05-23 2011-03-29 Bridgestone Corporation Method for making alkoxy-modified silsesquioxanes
WO2008145136A1 (en) 2007-05-30 2008-12-04 Aarhus Universitet Stat3 inactivation by inhibition of the folate receptor pathway
WO2009002993A1 (en) 2007-06-25 2008-12-31 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
CN101139613B (zh) 2007-08-01 2011-06-08 姜荣锡 抗肿瘤二元多肽及其应用与制备方法
MX2010006450A (es) * 2007-12-12 2010-12-15 Pincell Srl Remedios para penfigo que contienen anticuerpos antiligando de fas.
WO2009080759A1 (en) 2007-12-21 2009-07-02 Novartis Ag Organic compounds
US9274119B2 (en) 2008-01-11 2016-03-01 The University Of Tokyo Anti-CLDN6 antibody
WO2009092014A1 (en) 2008-01-18 2009-07-23 Gagnon Peter S Enhanced purification of antibodies and antibody fragments by apatite chromatography
JP5470817B2 (ja) 2008-03-10 2014-04-16 日産自動車株式会社 電池用電極およびこれを用いた電池、並びにその製造方法
WO2009132081A2 (en) 2008-04-24 2009-10-29 The Research Foundation Of State University Of New York Monoclonal antibody-based targeting of folate receptors
AU2009243009B2 (en) 2008-04-30 2014-09-11 Immunogen, Inc Potent conjugates and hydrophilic linkers
CA2722696C (en) 2008-04-30 2021-08-10 Immunogen, Inc. Cross-linkers and their uses
US8383351B2 (en) 2008-06-11 2013-02-26 Oxford Brookes University Antibody to inhibin/ activin β-B subunit
JP5675619B2 (ja) 2008-09-17 2015-02-25 エンドサイト, インク.Endocyte, Inc. 葉酸拮抗薬の葉酸受容体結合性コンジュゲート
WO2010033913A1 (en) 2008-09-22 2010-03-25 Icb International, Inc. Antibodies, analogs and uses thereof
CN101440130B (zh) 2008-11-21 2011-07-27 中国人民解放军第四军医大学 一种抗人IL-13Rα2单克隆抗体的重链和轻链的可变区
PL2378876T3 (pl) 2008-12-19 2019-06-28 Medicis Pharmaceutical Corporation Dawka imikwimodu o mniejszej sile i krótkie schematy dawkowania w leczeniu rogowacenia słonecznego
EP2995953B1 (en) 2009-03-24 2017-11-29 Biocept, Inc. Devices and methods of cell capture and analysis
JP5769316B2 (ja) 2009-08-06 2015-08-26 イムナス・ファーマ株式会社 Aβオリゴマーに特異的に結合する抗体およびその利用
PE20121689A1 (es) * 2009-10-09 2012-12-14 Sanofi Sa Polipeptidos para union al receptor para productos finales de glicosilacion avanzada asi como composiciones y metodos que implican a los mismos
AR080155A1 (es) 2010-02-10 2012-03-14 Immunogen Inc Anticuerpos anti-cd20 y su utilizacion
MY197016A (en) 2010-02-24 2023-05-20 Immunogen Inc Folate receptor 1 antibodies and immunoconjugates and uses thereof
BR112012022044A2 (pt) 2010-03-24 2020-08-25 Genentech Inc ''anticorpo,imunoconjugado,formulação farmacêutica,uso do anticorpo,método de tratamento,anticorpo biespecifico isolado e célula hospedeira''.
EP2629798A4 (en) 2010-10-20 2014-05-28 Morphotek Inc GLYCOFORMS OF ANTI-RECEPTOR ANTIBODY-ALPHA FOLATE (ANTI-FRA)
ES2627061T3 (es) 2010-11-05 2017-07-26 Morphotek, Inc. Folato receptor alfa como diagnóstico y pronóstico para el folato marcador receptor de los cánceres expresores de alfa
AU2012236403B2 (en) 2011-03-29 2016-08-04 Immunogen, Inc. Process for manufacturing conjugates of improved homogeneity
CN103717262B (zh) 2011-03-29 2017-09-15 伊缪诺金公司 通过一步法制备类美登素抗体缀合物
PT2694106T (pt) 2011-04-01 2018-03-05 Immunogen Inc Métodos para aumentar eficácia de terapia de cancro de folr1
US20120282282A1 (en) 2011-04-04 2012-11-08 Immunogen, Inc. Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates
WO2012145112A2 (en) 2011-04-18 2012-10-26 Immunogen, Inc. Novel maytansinoid derivatives with sulfoxide linker
EP2524929A1 (en) 2011-05-17 2012-11-21 Sanofi Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms
JP6220333B2 (ja) 2011-07-15 2017-10-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗葉酸受容体アルファ抗体およびその使用
SG10201804260QA (en) 2012-08-31 2018-07-30 Immunogen Inc Diagnostic assays and kits for detection of folate receptor 1
WO2014055842A1 (en) 2012-10-04 2014-04-10 Immunogen, Inc. Process for preparing stable antibody maytansinoid conjugates
JP6136279B2 (ja) 2013-01-15 2017-05-31 株式会社ジェイテクト 転がり軸受装置
TWI503850B (zh) 2013-03-22 2015-10-11 Polytronics Technology Corp 過電流保護元件
BR112015028244A2 (pt) 2013-05-14 2017-09-19 Immunogen Inc Imunoconjugado que se liga ao folr1 e seu uso
WO2015026909A2 (en) 2013-08-23 2015-02-26 Nuclea Biotechnologies, Inc. Msia-srm assay for biomarker analysis
JP2016536330A (ja) 2013-08-30 2016-11-24 イミュノジェン, インコーポレイテッド 葉酸受容体1の検出用の抗体及びアッセイ
TWI510996B (zh) 2013-10-03 2015-12-01 Acer Inc 控制觸控面板的方法以及使用該方法的可攜式電腦
EP4424323A3 (en) 2013-10-08 2024-11-13 ImmunoGen, Inc. Anti-folr1 immunoconjugate dosing regimens
US20150297744A1 (en) 2014-03-28 2015-10-22 Immunogen, Inc. Anti-FOLR1 Immunoconjugate Dosing Regimens
KR20170027805A (ko) 2014-07-01 2017-03-10 익스프레션 패톨로지, 인크. 화학요법 표적에 대한 srm 검정
US20160058884A1 (en) 2014-09-02 2016-03-03 Immunogen, Inc. Methods for formulating antibody drug conjugate compositions
WO2017049149A1 (en) 2015-09-17 2017-03-23 Immunogen, Inc. Therapeutic combinations comprising anti-folr1 immunoconjugates
EP3165928B1 (en) 2015-11-06 2019-01-09 Promise Advanced Proteomics A method for quantifying anti-tnf antibodies
US9816280B1 (en) 2016-11-02 2017-11-14 Matthew Reitnauer Portable floor
WO2019050935A1 (en) 2017-09-05 2019-03-14 Immunogen, Inc. METHODS OF DETECTING FOLATE RECEPTOR 1 IN A SAMPLE FROM A PATIENT
WO2019060718A1 (en) 2017-09-22 2019-03-28 Immunogen, Inc. SEPARATION OF LIGHT TRIPLE CHAIN ANTIBODIES USING CATION EXCHANGE CHROMATOGRAPHY
CN111587125A (zh) 2018-01-12 2020-08-25 伊缪诺金公司 抗体药物缀合、纯化和调配的方法
KR20220004687A (ko) 2019-04-29 2022-01-11 이뮤노젠 아이엔씨 이중파라토프 fr-알파 항체 및 면역접합체

Similar Documents

Publication Publication Date Title
JP2016536330A5 (show.php)
JP6484562B2 (ja) 可溶性gpc3タンパク質の測定方法
JP2015533788A5 (show.php)
RU2651513C2 (ru) Новое антитело для диагностики и (или) прогнозирования рака
RU2015108348A (ru) Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения
JP2015525208A5 (show.php)
RU2017107773A (ru) Антитела, специфичные к ммр9
JP2012019790A5 (show.php)
JP7096667B2 (ja) Gpc3標的治療剤が有効である患者に投与されるgpc3標的治療剤
MX2010009103A (es) Panel biomarcador de carcinoma de pulmon de celula pequeña.
CN107022030B (zh) 检测甲胎蛋白的单克隆抗体及试剂盒和应用
ES2848857T3 (es) Anticuerpos monoclonales humanos contra EphA4 y su uso
CN104755496A (zh) 作为癌症治疗和诊断靶标的ly75
US20160159888A1 (en) Anti-s100a4 antibody molecules and their uses
JPWO2021075545A5 (show.php)
CN114044823B (zh) 靶向钙粘蛋白17的纳米抗体及其应用
CN103842823B (zh) 用于胸膜间皮瘤患者的早期发现的分子标志物及其表达分析方法
RU2013104137A (ru) Изоформы bard1 при раке легкого и колоректальном раке и их применение
WO2015097928A1 (ja) 可溶性gpc3タンパク質の測定方法
JP6977105B2 (ja) Igf−1r抗体および癌の診断のためのその使用
JPWO2014192974A1 (ja) 抗lgr6抗体を含む癌の検出用又は診断用試薬
JP2018520366A5 (show.php)
KR20250165646A (ko) Nr1에 대한 자가항체의 검출
ES2797089T3 (es) Anticuerpo IGF-1R y su utilización para el diagnóstico del cáncer
TW201840588A (zh) 抗gpr20抗體